Our medicines

Medicines commercialized by Juvisé Pharmaceuticals

10 medicines for patient use in nearly 80 countries

Below is a global list of products marketed by Juvisé Pharmaceuticals. The availability of medicines and the indications for which they are approved may vary with country and region.

For country-specific information, please contact us.

Arimidex® (anastrozole)

Please refer to the full prescribing information approved by the relevant national competent authority of the country where you are located.

For country-specific information, you may also contact us.

Casodex® (bicalutamide)

Please refer to the full prescribing information approved by the relevant national competent of the country where you are located.

For country-specific information, you may also contact us.

Digoxine-Juvisé® (digoxin)

Please refer to the full prescribing information approved by the relevant national competent authority of the country where you are located.

For country-specific information, you may also contact us.

Entumin® / Entumine® / Etomine® / Etumina® / Etumine® (clotiapine)

Please refer to the full prescribing information approved by the relevant national competent authority of the country where you are located.

For country-specific information, you may also contact us.

Esidrex® (hydrochlorothiazide)

Please refer to the full prescribing information approved by the relevant national competent authority of the country where you are located.

For country-specific information, you may also contact us.

Insidon® (opipramol)

Please refer to the full prescribing information approved by the relevant national competent authority of the country where you are located.

For country-specific information, you may also contact us.

Lumirelax® (methocarbamol)

Please refer to the full prescribing information approved by the relevant national competent authority of the country where you are located.

For country-specific information, you may also contact us.

Pylera® (bismuth subcitrate potassium + metronidazole + tetracycline hydrochloride)

Please refer to the full prescribing information approved by the relevant national competent authority of the country where you are located.

For country-specific information, you may also contact us.

Sintrom® (acenocoumarol)

Please refer to the full prescribing information approved by the relevant national competent authority of the country where you are located.

For country-specific information, you may also contact us.

JUV-FRA-202408-0210, 09/2024

A question about one of our medicines?

If you have any questions about one of our medicines or if you would like to report an adverse event